| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP3-16893-20ul | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-89199-50ul | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-34658-0.1mg | |||
| Conjugate | Catalog # | Availability | Size | Price |
|---|---|---|---|---|
| HRP | NBP2-79433-5Plates | |||
![Western Blot: VEGFR2/KDR/Flk-1 [p Tyr1175] Antibody [NBP3-16893] - Western blot analysis of extracts of NIH/3T3 cells, using VEGFR2/KDR/Flk-1 antibody (NBP3-16893) at 1:1000 dilution.NIH/3T3 cells were treated by EGF (100 ng/ml) at 37C for 30 minutes after serum-starvation overnight. Secondary antibody: HRP Goat Anti-Rabbit IgG (H+L) at 1:10000 dilution. Lysates/proteins: 25ug per lane. Blocking buffer: 3% nonfat dry milk in TBST. Detection: ECL Basic Kit. Exposure time: 180s.](http://images.novusbio.com/fullsize/VEGFR2-KDR-Flk-1-[p-Tyr1175]-Antibody-Western-Blot-NBP3-16893-img0001.jpg "Western Blot: VEGFR2/KDR/Flk-1 [p Tyr1175] Antibody [NBP3-16893] - Western blot analysis of extracts of NIH/3T3 cells, using VEGFR2/KDR/Flk-1 antibody (NBP3-16893) at 1:1000 dilution.NIH/3T3 cells were treated by EGF (100 ng/ml) at 37C for 30 minutes after serum-starvation overnight. Secondary antibody: HRP Goat Anti-Rabbit IgG (H+L) at 1:10000 dilution. Lysates/proteins: 25ug per lane. Blocking buffer: 3% nonfat dry milk in TBST. Detection: ECL Basic Kit. Exposure time: 180s.")
![Western Blot: VEGFR2/KDR/Flk-1 [p Tyr1175] Antibody - Azide and BSA Free [NBP3-16893] - Western blot analysis of lysates from A-431 cells, using VEGFR2/KDR/Flk-1 Rabbit pAb at 1:500 dilution. A-431 cells were treated by EGF (100 ng/ml) at 37C for 30 minutes after serum-starvation overnight.Secondary antibody: HRP-conjugated Goat anti-Rabbit IgG (H+L) at 1:10000 dilution.Lysates/proteins: 25ug per lane.Blocking buffer: 3% nonfat dry milk in TBST.Detection: ECL Basic Kit.Exposure time: 1s.](http://images.novusbio.com/fullsize/nbp3-16893_rabbit-vegfr2-kdr-flk-1-p-tyr-1175-pab-52202511374126.jpg)
![Immunohistochemistry-Paraffin: VEGFR2/KDR/Flk-1 Antibody [NB100-686] - Formalin fixed paraffin embedded human angiosarcoma stained with Flk-1 antibody (NB100-686).](http://images.novusbio.com/fullsize/VEGFR2-KDR-Flk-1-Antibody-Immunohistochemistry-Paraffin-NB100-686-img0004.jpg "Immunohistochemistry-Paraffin: VEGFR2/KDR/Flk-1 Antibody [NB100-686] - Formalin fixed paraffin embedded human angiosarcoma stained with Flk-1 antibody (NB100-686).")
![ELISA: Rat VEGFR2/KDR/Flk-1 ELISA Kit (Colorimetric) [NBP2-78888] - Samples were spiked with high concentrations of Rat VEGFR2/KDR/Flk-1 and diluted with Reference Standard & Sample Diluent to produce samples with values within the range of the assay.](http://images.novusbio.com/fullsize/nbp2-78888_rat-vegfr2-kdr-flk-1-elisa-kit-colorimetric-132202416221064.jpg "ELISA: Rat VEGFR2/KDR/Flk-1 ELISA Kit (Colorimetric) [NBP2-78888] - Samples were spiked with high concentrations of Rat VEGFR2/KDR/Flk-1 and diluted with Reference Standard & Sample Diluent to produce samples with values within the range of the assay.")
![ELISA: Rat VEGFR2/KDR/Flk-1 ELISA Kit (Colorimetric) [NBP2-78888] - Standard Curve Reference](http://images.novusbio.com/fullsize/nbp2-78888_rat-vegfr2-kdr-flk-1-elisa-kit-colorimetric-432024920262.jpg)
![Flow Cytometry: VEGFR2/KDR/Flk-1 Antibody (001) [NBP2-89199] - Analysis of Human VEGFR2(CD309) expression on HUVEC cells. Cells were stained with purified anti-Human VEGFR2(CD309), then a FITC-conjugated second step antibody. The fluorescence histograms were derived from gated events with the forward and side light-scatter characteristics of intact cells.](http://images.novusbio.com/fullsize/VEGFR2-KDR-Flk-1-Antibody-001-Flow-Cytometry-NBP2-89199-img0001.jpg "Flow Cytometry: VEGFR2/KDR/Flk-1 Antibody (001) [NBP2-89199] - Analysis of Human VEGFR2(CD309) expression on HUVEC cells. Cells were stained with purified anti-Human VEGFR2(CD309), then a FITC-conjugated second step antibody. The fluorescence histograms were derived from gated events with the forward and side light-scatter characteristics of intact cells.")
![SDS-Page: Recombinant Human VEGF Receptor 2/3 Protein [NBP2-59909] - 15% SDS-PAGE](http://images.novusbio.com/fullsize/Recombinant-Human-VEGF-Receptor-2-3-Protein-SDS-Page-NBP2-59909-img0001.jpg "SDS-Page: Recombinant Human VEGF Receptor 2/3 Protein [NBP2-59909] - 15% SDS-PAGE")
![ELISA: VEGF R2/KDR/Flk-1 ELISA Kit [NBP1-83729] - Standard curve](http://images.novusbio.com/fullsize/VEGF-R2-KDR-Flk-1-ELISA-Kit-ELISA-NBP1-83729-img0001.jpg "ELISA: VEGF R2/KDR/Flk-1 ELISA Kit [NBP1-83729] - Standard curve")
![Sandwich ELISA: VEGFR2/KDR/Flk-1 Antibody Pair [HRP] [NBP2-79433]](http://images.novusbio.com/fullsize/VEGFR2-KDR-Flk-1-Antibody-Pair-[HRP]-Sandwich-ELISA-NBP2-79433-img0001.jpg "Sandwich ELISA: VEGFR2/KDR/Flk-1 Antibody Pair [HRP] [NBP2-79433]")